MRI Limited Launches MetaReports.net - A Dynamic New Proprietary Platform For Publishing Hi-Tech Industry Research Reports

MetaReports.net, a new online service featuring a novel proprietary platform for conducting and publishing Hi-Tech industry market research has been launched by MetaResearch International Ltd. MetaReports.net’s unique approach ensures neutrality of the research and addresses the unmet need of analyzing new unproven technologies and future innovation-dependant markets.

"Coronary Angiogenesis – The Promised Next Best Thing In Cardiology Practice,” is the title of now available inaugural Cardio Series track for the www.MetaReports.net portfolio. This MetaReport addresses hitherto unaddressed issues that have created road blocks in the development of this path breaking technology for growing natural bypass to the blocked coronary arteries.

“Our latest work product on Coronary Angiogenesis is a perfect example of the difference between reporting what is out there versus what is missing, and ways of recruiting the missing.” States Dr Fazal Raheman CEO, MRI Limited.

“During my previous two decades of engagement with various Hi-Tech start-ups, I noticed a need for market research reporting platform that focuses its research more on the robustness of the new unproven but emerging technology, rather than future market size and equity projections. If the technology falters all equity projections become meaningless,” Dr Raheman explains his motivation behind developing the MetaReports.net platform.

Unfortunately most market research reports published are authored by non-technical analysts. As a result their future projections rely on the technical information based on their interactions with those scientists who are already biased one way or the other. In reference to companies that are still wrestling with novel unproven technologies and in terms of future technology-dependant markets that do not exist today, such approach is mostly inadequate. “Coronary Angiogenesis is another example where earlier research reports have failed in their projections and contributed nothing in terms of building up the industry. MetaReports.net will fill that void.” Dr Raheman concludes.


About MRI Limited
MRI Limited, a British Corporation with operations in Dubai, is a technology development and consulting outfit with expertise ranging from inventing new therapeutics and disease management approaches to developing intangible knowledge assets into commercially quantifiable intellectual properties. MRI conducts in-house as well as contract research for clients. MetaReports.net currently operates as a division of MRI Limited.

Contact Information

Fazal Raheman MD

CEO

MRI Limited

Contact via E-mail